Key Players Contributions to Grace Up the US Injection Pen Market Growth
Published: Nov 2020
The US injection pen market is anticipated to grow at a CAGR of 6.1% over the forecast period (2020-2026). The key factors that primarily drives the market include the presence of a large pool of players operating in the market. Eli Lily & Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., Becton, Dickinson & Co., Novo Nordisk A/S, and AstraZeneca Plc are some of the key players operating in the US injection pen industry.
North American Injection Pen Market is Largely Driven by a Large Diabetic Patient Pool
Published: Nov 2020
The North American injection pen market is anticipated to grow at a CAGR of 6.2% over the forecast period (2020-2026). The market is primarily driven by the presence of a large pool of diabetic patients in the region. As per the IDF, in North America, the prevalence of diabetes is approximately 13.3% of the total adult population in the region which is projected to reach up to 14.2% by 2030 and further reach up to 15% by 2045.
Increasing Approvals for Monoclonal Antibodies is Reflecting Positively on European monoclonal antibodies Market
Published: Nov 2020
European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for monoclonal antibodies has been reported in the region, owing to the rising demand for novel monoclonal antibody therapies with higher safety and efficacy in the region.
Increasing COVID-19 Trials to Provide Opportunity for China Monoclonal Antibodies Market
Published: Nov 2020
China monoclonal antibodies market is estimated to grow at a CAGR of nearly 9.2% during the forecast period. An increasing monoclonal antibody COVID-19 trials are offering scope for market growth. For instance, in June 2020, Chinese scientists introduced a phase I trial for the first neutralizing COVID-19 antibody treatment globally.
Significant Rise in Cancer Incidences to Drive Asia-Pacific Monoclonal Antibodies Market
Published: Nov 2020
Asia-Pacific monoclonal antibodies market is estimated to grow at a CAGR of 8.9% during the forecast period. Rising cancer incidences is the major factor in accelerating market growth. As per the World Health Organization (WHO), there were 4.3 million new cancer incidences reported in the country. Of these, lung (18.1%), colorectum (12.2%), stomach (10.6%), liver (9.2%), breast (8.6%), and other cancers (41.4%) of all new cancer cases in the country.
Increasing COVID-19 Trials is Offering an Opportunity for Global Monoclonal Antibodies Market
Published: Nov 2020
The global monoclonal antibodies market is estimated to grow at a CAGR of 8.6% during the forecast period. An increasing number of trials for monoclonal antibodies for COVID-19 patients. For instance, in October 2020, Celltrion Group declared the introduction of its Phase III clinical trial investigating CT-P59. It is an anti-COVID-19 monoclonal antibody therapy candidate.
Rising Prevalence and Spending on Cancer will Escalate the US Peptide Therapeutics Market
Published: Nov 2020
The US peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. The burden of cancer is growing at an alarming pace across the country. According to the Centers for Disease Control and Prevention (CDC), by end of 2020, the number of new cancer cases is expected increase from around 24% in men to more than one million cases every year in the US, and by about 21% in women to more than 900,000 cases per year in the country.
Technological Advancement in UK Pharma Industry will Escalate the UK Peptide Therapeutics Market
Published: Nov 2020
The UK peptide therapeutics market will see a considerable growth of 3.7% during the forecast period. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the acceptance of peptide therapeutics in the UK for the treatment of various health conditions, such as CVD, cancer, and others.
Extensive R&D Inpeptide for Novel Drugs will Escalate the North American Peptide Therapeutics Market
Published: Nov 2020
The North American peptide therapeutics market will see a considerable growth of 5.1% during the forecast period. The region has a significant presence of peptide therapeutics manufacturers, with extensive R&D in the peptide therapeutics market. The Peptide Therapeutics Foundation, a not-for-profit 501C (3) was also established in 2008 in the region with the intention to promote R&D of peptide therapeutics.
Rise in Peptide Synthesis Services in India is Escalating Indian Peptide Therapeutics Market
Published: Nov 2020
Indian peptide therapeutics market will see a considerable growth of 7.6% during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs.